WallStSmart

Certara Inc (CERT)vsHinge Health, Inc. (HNGE)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Hinge Health, Inc. generates 54% more annual revenue ($646.34M vs $419.75M). CERT leads profitability with a -3.6% profit margin vs -78.9%. CERT earns a higher WallStSmart Score of 37/100 (F).

CERT

Hold

37

out of 100

Grade: F

Growth: 4.0Profit: 3.0Value: 6.7Quality: 7.0
Piotroski: 5/9Altman Z: 1.63

HNGE

Hold

36

out of 100

Grade: F

Growth: 7.3Profit: 3.5Value: 5.0Quality: 5.0
Piotroski: 3/9Altman Z: -2.69
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CERTUndervalued (+55.5%)

Margin of Safety

+55.5%

Fair Value

$15.56

Current Price

$5.37

$10.19 discount

UndervaluedFair: $15.56Overvalued

Intrinsic value data unavailable for HNGE.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CERT2 strengths · Avg: 10.0/10
Price/BookValuation
0.8x10/10

Reasonable price relative to book value

Debt/EquityHealth
0.0110/10

Conservative balance sheet, low leverage

HNGE2 strengths · Avg: 10.0/10
Revenue GrowthGrowth
47.2%10/10

Revenue surging 47.2% year-over-year

Debt/EquityHealth
0.0210/10

Conservative balance sheet, low leverage

Areas to Watch

CERT4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.9%4/10

0.9% revenue growth

Altman Z-ScoreHealth
1.634/10

Distress zone — elevated risk

Market CapQuality
$808.94M3/10

Smaller company, higher risk/reward

Operating MarginProfitability
3.8%3/10

Operating margin of 3.8%

HNGE4 concerns · Avg: 2.3/10
Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Price/BookValuation
43.4x2/10

Trading at 43.4x book value

Return on EquityProfitability
-197.2%2/10

ROE of -197.2% — below average capital efficiency

EPS GrowthGrowth
-68.4%2/10

Earnings declined 68.4%

Comparative Analysis Report

WallStSmart Research

Bull Case : CERT

The strongest argument for CERT centers on Price/Book, Debt/Equity.

Bull Case : HNGE

The strongest argument for HNGE centers on Revenue Growth, Debt/Equity. Revenue growth of 47.2% demonstrates continued momentum.

Bear Case : CERT

The primary concerns for CERT are Revenue Growth, Altman Z-Score, Market Cap.

Bear Case : HNGE

The primary concerns for HNGE are Piotroski F-Score, Price/Book, Return on Equity.

Key Dynamics to Monitor

CERT profiles as a turnaround stock while HNGE is a hypergrowth play — different risk/reward profiles.

HNGE is growing revenue faster at 47.2% — sustainability is the question.

HNGE generates stronger free cash flow (43M), providing more financial flexibility.

Monitor HEALTH INFORMATION SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CERT scores higher overall (37/100 vs 36/100). Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Certara Inc

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Certara Inc. provides software products and technology services to clients for biosimulation in drug discovery, preclinical and clinical research, regulatory filings, and market access. The company is headquartered in Princeton, New Jersey.

Hinge Health, Inc.

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Hinge Health, Inc. develops health care software for joint and muscle health. The company is headquartered in San Francisco, California.

Visit Website →

Want to dig deeper into these stocks?